Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
10
TGA:10
Drug Approvals
mRESVIA respiratory syncytial virus F protein mRNA (nucleoside modified), 50 micrograms in 0.5 mL, suspension for injection, prefilled syringe. (411450)
- Product Name
- mRESVIA respiratory syncytial virus F protein mRNA (nucleoside modified), 50 micrograms in 0.5 mL, suspension for injection, prefilled syringe.
- Approval Date
- Mar 28, 2025
TGA
SPIKEVAX JN.1 (SARS-CoV-2 JN.1 mRNA) COVID-19 VACCINE 0.1 mg/mL suspension for injection pre-filled syringe (458805)
- Product Name
- SPIKEVAX JN.1 (SARS-CoV-2 JN.1 mRNA) COVID-19 VACCINE 0.1 mg/mL suspension for injection pre-filled syringe
- Approval Date
- Nov 15, 2024
TGA
SPIKEVAX XBB.1.5 (andusomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial - single-dose (418910)
- Product Name
- SPIKEVAX XBB.1.5 (andusomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial - single-dose
- Approval Date
- Oct 10, 2023
TGA
SPIKEVAX XBB.1.5 (andusomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection pre-filled syringe (418911)
- Product Name
- SPIKEVAX XBB.1.5 (andusomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection pre-filled syringe
- Approval Date
- Oct 10, 2023
TGA
SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 (elasomeran/davesomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial-single dose (406730)
- Product Name
- SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 (elasomeran/davesomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial-single dose
- Approval Date
- Jun 8, 2023
TGA
SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 (elasomeran/davesomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection pre-filled syringe (399553)
- Product Name
- SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 (elasomeran/davesomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection pre-filled syringe
- Approval Date
- Feb 20, 2023
TGA
SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 (elasomeran/davesomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial (399552)
- Product Name
- SPIKEVAX BIVALENT ORIGINAL/OMICRON BA.4-5 (elasomeran/davesomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial
- Approval Date
- Feb 20, 2023
TGA
SPIKEVAX (elasomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial - multidose (388244)
- Product Name
- SPIKEVAX (elasomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection vial - multidose
- Approval Date
- Jul 19, 2022
TGA
SPIKEVAX (elasomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection pre-filled syringe (388245)
- Product Name
- SPIKEVAX (elasomeran) COVID-19 VACCINE 0.1 mg/mL suspension for injection pre-filled syringe
- Approval Date
- Jul 19, 2022
TGA
SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial (370599)
- Product Name
- SPIKEVAX (elasomeran) COVID-19 VACCINE 0.2 mg/mL suspension for injection vial
- Approval Date
- Aug 9, 2021
TGA
Clinical Trials
No trials found
News
No news found